RecruitingNCT07030153

Association of Genetic Variants With Myopia

Genetic Variants and Their Association With Myopia Risk, Progression, and Optimal Interventions in Children

Sponsor

Beijing Visionly Plus Eye Hospital

Enrollment

1,000 participants

Start Date

Jul 1, 2025

Study Type

OBSERVATIONAL

Conditions

Myopia

Summary

This study aims to identify genetic factors linked to myopia, including those that influence a person's risk of developing it and how quickly it progresses (like changes in eye length). It will also examine how different treatments-such as low-dose atropine drops, orthokeratology lenses, specialized glasses, and increased outdoor time-interact with these genes. Finally, the research will develop a genetic risk score to help tailor personalized myopia prevention and treatment plans.

Eligibility

Min Age: 6 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Oral swab DNA analyzed for myopia-related gene variants for people with myopia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 6 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICOral swab DNA analyzed for myopia-related gene variants

Beyond detecting links between gene variants and myopia development, the testing analyzes how these variants influence treatment effectiveness. The aim is to enable early risk prediction and personalized treatment guidance for children through oral DNA testing.